Stephens Consulting’s AdaptHealth AHCO Stock Holding History

Stephens Consulting’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-35	Closed	-$380	–	1211
2025 Q1	$380	Buy	+35	New	+$352	﹤0.01%	1133

Other funds holding AHCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Stephens Consulting's AHCO Position: Q2 2025 in Review

Stephens Consulting sold out of AdaptHealth (AHCO) in Q2 2025, closing a stake of 35 shares — an estimated $380 sold.

Stephens Consulting first reported a position in AHCO in Q1 2025 and held it in 1 quarter. The position peaked at $380 in Q1 2025. 218 funds tracked by Wall St. Rank hold AHCO as of Q2 2025.

Stephens Consulting reported no remaining AdaptHealth position as of Q2 2025 after selling out during the quarter.
Stephens Consulting sold 35 AdaptHealth shares in Q2 2025, an estimated $380.
Stephens Consulting first reported a position in AdaptHealth in Q1 2025 and held it in 1 quarter.
Stephens Consulting's AdaptHealth position peaked at $380 in Q1 2025.
218 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2025.

Based on Stephens Consulting's 13F filing for Q2 2025, filed 25 Jul 2025.